Free Trial

Index Fund Advisors Inc. Takes $352,000 Position in U.S. Physical Therapy, Inc. $USPH

U.S. Physical Therapy logo with Medical background

Key Points

  • Index Fund Advisors Inc. acquired a new position in U.S. Physical Therapy, Inc. during Q2, purchasing 4,505 shares valued at approximately $352,000.
  • Analysts have mixed ratings on U.S. Physical Therapy, with an average target price of $110.25, indicating expectations for growth despite a recent "hold" rating from Wall Street Zen.
  • The company announced a quarterly dividend of $0.45 per share, resulting in a 2.1% dividend yield and a payout ratio of 78.60%.
  • MarketBeat previews top five stocks to own in November.

Index Fund Advisors Inc. purchased a new position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,505 shares of the company's stock, valued at approximately $352,000.

A number of other institutional investors have also recently modified their holdings of USPH. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after buying an additional 400 shares during the last quarter. Parallel Advisors LLC boosted its position in U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company's stock worth $35,000 after purchasing an additional 213 shares during the last quarter. CWM LLC lifted its position in shares of U.S. Physical Therapy by 207.4% during the 2nd quarter. CWM LLC now owns 827 shares of the company's stock valued at $65,000 after buying an additional 558 shares in the last quarter. Fifth Third Bancorp lifted its position in shares of U.S. Physical Therapy by 34.6% during the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after buying an additional 265 shares in the last quarter. Finally, AlphaQuest LLC purchased a new position in shares of U.S. Physical Therapy during the 1st quarter valued at about $92,000.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Zacks Research raised U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. JPMorgan Chase & Co. began coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They issued an "overweight" rating and a $110.00 price target on the stock. Wall Street Zen cut U.S. Physical Therapy from a "buy" rating to a "hold" rating in a report on Sunday, September 21st. Barrington Research boosted their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and an average target price of $110.25.

Read Our Latest Analysis on U.S. Physical Therapy

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $87.52 on Monday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.19. The stock's 50 day simple moving average is $83.62 and its two-hundred day simple moving average is $77.41. The company has a market cap of $1.33 billion, a price-to-earnings ratio of 38.22, a PEG ratio of 4.40 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The business had revenue of $140.66 million for the quarter. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 22nd were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.1%. U.S. Physical Therapy's payout ratio is currently 78.60%.

Insider Activity

In other news, COO Graham D. Reeve sold 1,792 shares of the business's stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $86.57, for a total transaction of $155,133.44. Following the transaction, the chief operating officer owned 22,246 shares of the company's stock, valued at approximately $1,925,836.22. The trade was a 7.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Nancy Ham sold 600 shares of the business's stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $81.71, for a total value of $49,026.00. Following the transaction, the director directly owned 1,994 shares in the company, valued at approximately $162,929.74. This represents a 23.13% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,853 shares of company stock worth $581,406. Company insiders own 2.00% of the company's stock.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.